Frontiers Safety and therapeutic effects of personalized

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial - The Lancet Oncology

Cancer vaccines: the next immunotherapy frontier

Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis - The Lancet Microbe

Frontiers of multimodal learning: A responsible AI approach - Microsoft Research

Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management

Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer

Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine

Frontiers Components, prospects and challenges of personalized prevention

Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial - The Lancet Gastroenterology & Hepatology

Cells, Free Full-Text

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial - The Lancet Neurology

AI can make healthcare more accurate, accessible, and sustainable

NIH Music-Based Intervention Toolkit

Presenting a sham treatment as personalised increases the placebo effect in a randomised controlled trial

Targeting Affordability in Healthcare: A Review of the Evidence – USC Schaeffer